Financial statements Biogenetica International Laboratories

Balance sheet of Biogenetica International Laboratories

Company age:
Age:
12 y. 4 m. 8 d.
Share capital:
Share capital:
625 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of BIOGENETICA INTERNATIONAL LABORATORIES

Year
2018
2019
2020
2021
Total assets 109 320,97 87 872,25 70 450,59 54 237,98
A. Fixed assets 87 069,92 66 224,43 48 514,77 30 805,11
B. Current assets 22 251,05 21 647,82 21 935,82 23 432,87
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00
Total liabilities 109 320,97 87 872,25 70 450,59 54 237,98
A. Equity 9 779,62 -17 199,55 -41 860,53 -68 177,09
B. Liabilities and provisions for liabilities 99 541,35 105 071,80 112 311,12 122 415,07
I. Long-term liabilities 38 749,52 40 389,50 42 029,48 43 669,46
II. Short-term liabilities 60 791,83 64 682,30 70 281,64 78 745,61
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.